Stay updated on Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.

Latest updates to the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page
- Check6 days agoChange DetectedA new revision tag 'Revision: v3.5.4' has been added to the study record, and the previous revision 'Revision: v3.5.3' has been removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, indicating a minor site software/version update without changing the study details.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated to v3.5.0, replacing v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.4.3 was applied; no changes to the study details are evident.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page now shows Revision: v3.4.2 and the previous government-funding status notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.